Ubiquitin protein ligase 3D structures
From Proteopedia
(Difference between revisions)
Line 28: | Line 28: | ||
**[[5trb]] – hUPL RNF20 domain<br /> | **[[5trb]] – hUPL RNF20 domain<br /> | ||
**[[4r7e]] – hUPL RING domain<br /> | **[[4r7e]] – hUPL RING domain<br /> | ||
- | |||
- | *'''Ubiquitin protein ligase cereblon''' | ||
- | |||
- | **[[5v3o]] – hCRBN + DNA damage-binding protein <br /> | ||
- | **[[5hxb]] – hCRBN + DNA damage-binding protein + eukaryotic peptide chain release factor<br /> | ||
- | **[[5fqd]] – hCRBN + DNA damage-binding protein + casein kinase I + lenalidomide<br /> | ||
- | **[[4tz4]] – hCRBN + DNA damage-binding protein + lenalidomide<br /> | ||
- | **[[6bnb]], [[6bn7]], [[6bn8]], [[6bn9]], [[6boy]] – hCRBN + DNA damage-binding protein + bromodomain-containing protein<br /> | ||
- | **[[3wx1]], [[3wx2]] – mCRBN thalidomide-binding domain - mouse<br /> | ||
- | **[[4tzc]], [[5yiz]], [[5yj0]], [[5yj1]] – mCRBN thalidomide-binding domain + thalidomide<br /> | ||
- | **[[4tzu]] – mCRBN thalidomide-binding domain + pomalidomide<br /> | ||
- | **[[4ci1]] – cCRBN + DNA damage-binding protein + thalidomide - chicken<br /> | ||
- | **[[4ci2]] – cCRBN + DNA damage-binding protein + lenalidomide<br /> | ||
- | **[[4ci3]] – cCRBN + DNA damage-binding protein + pomalidomide<br /> | ||
- | **[[5ami]] – MgCRBN 4 – ''Magnetospirillum griphyswaldense''<br /> | ||
- | **[[5amh]], [[5maj]], [[5amk]], [[4v2r]] – MgCer 4 + thalidomide<br /> | ||
- | **[[4v32]] – MgCRBN 4 (mutant) + thalidomide<br /> | ||
- | **[[4v2z]], [[4v30]], [[6r0c]], [[8r0s]], [[6r0u]], [[6r0v]], [[6r1d]] – MgCRBN 4 + thalidomide derivative<br /> | ||
- | **[[4v31]] – MgCRBN 4 + deoxyuridine<br /> | ||
- | **[[6r11]], [[6r13]], [[6r18]], [[6r19]], [[6r1a]], [[6r1c]], [[6r1k]], [[6r1w]], [[6r1x]] – MgCRBN 4 + effector<br /> | ||
- | |||
- | *'''Ubiquitin protein ligase CHFR''' | ||
- | |||
- | **[[2xoc]], [[2xoy]], [[2xoz]] – hUPL C terminal + nucleotide<br /> | ||
- | **[[2xp0]] – hUPL C terminal <br /> | ||
*'''Ubiquitin protein ligase Cbl''' Domains:Tyr kinase-binding (TKB) 25-351;RING 358-437;WW3 399-432;catalytic 495-852; UBA 924-973-432 | *'''Ubiquitin protein ligase Cbl''' Domains:Tyr kinase-binding (TKB) 25-351;RING 358-437;WW3 399-432;catalytic 495-852; UBA 924-973-432 | ||
Line 74: | Line 49: | ||
**[[1yvh]] – hUPL TKB domain + APS adaptor protein<br /> | **[[1yvh]] – hUPL TKB domain + APS adaptor protein<br /> | ||
**[[3bum]], [[3bun]], [[3buo]], [[3buw]], [[3bux]], [[3ob1]], [[3ob2]], [[3rlf]], [[3pfv]], [[2k4d]], [[4gpl]] – hUPL TKB domain + peptide <br /> | **[[3bum]], [[3bun]], [[3buo]], [[3buw]], [[3bux]], [[3ob1]], [[3ob2]], [[3rlf]], [[3pfv]], [[2k4d]], [[4gpl]] – hUPL TKB domain + peptide <br /> | ||
+ | **[[6o02]], [[6o03]] – hUPL TKB domain + monobody<br /> | ||
**[[2y1n]] – hUPL residues 47-435 + ZAP peptide <br /> | **[[2y1n]] – hUPL residues 47-435 + ZAP peptide <br /> | ||
**[[5o76]] – hUPL residues 47-435 (mutant) + ZAP peptide <br /> | **[[5o76]] – hUPL residues 47-435 (mutant) + ZAP peptide <br /> | ||
**[[4a49]] – hUPL RING domain + ubiquitin conjugating enzyme E2 <br /> | **[[4a49]] – hUPL RING domain + ubiquitin conjugating enzyme E2 <br /> | ||
**[[5axi]] – mUPL-B TKB domain + cblin <br /> | **[[5axi]] – mUPL-B TKB domain + cblin <br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase cereblon''' | ||
+ | |||
+ | **[[5v3o]] – hCRBN + DNA damage-binding protein <br /> | ||
+ | **[[5hxb]] – hCRBN + DNA damage-binding protein + eukaryotic peptide chain release factor<br /> | ||
+ | **[[5fqd]] – hCRBN + DNA damage-binding protein + casein kinase I + lenalidomide<br /> | ||
+ | **[[4tz4]] – hCRBN + DNA damage-binding protein + lenalidomide<br /> | ||
+ | **[[6bnb]], [[6bn7]], [[6bn8]], [[6bn9]], [[6boy]] – hCRBN + DNA damage-binding protein + bromodomain-containing protein<br /> | ||
+ | **[[3wx1]], [[3wx2]] – mCRBN thalidomide-binding domain - mouse<br /> | ||
+ | **[[4tzc]], [[5yiz]], [[5yj0]], [[5yj1]] – mCRBN thalidomide-binding domain + thalidomide<br /> | ||
+ | **[[4tzu]] – mCRBN thalidomide-binding domain + pomalidomide<br /> | ||
+ | **[[4ci1]] – cCRBN + DNA damage-binding protein + thalidomide - chicken<br /> | ||
+ | **[[4ci2]] – cCRBN + DNA damage-binding protein + lenalidomide<br /> | ||
+ | **[[4ci3]] – cCRBN + DNA damage-binding protein + pomalidomide<br /> | ||
+ | **[[5ami]] – MgCRBN 4 – ''Magnetospirillum griphyswaldense''<br /> | ||
+ | **[[5amh]], [[5maj]], [[5amk]], [[4v2r]] – MgCer 4 + thalidomide<br /> | ||
+ | **[[4v32]] – MgCRBN 4 (mutant) + thalidomide<br /> | ||
+ | **[[4v2z]], [[4v30]], [[6r0c]], [[8r0s]], [[6r0u]], [[6r0v]], [[6r1d]] – MgCRBN 4 + thalidomide derivative<br /> | ||
+ | **[[4v31]] – MgCRBN 4 + deoxyuridine<br /> | ||
+ | **[[6r11]], [[6r13]], [[6r18]], [[6r19]], [[6r1a]], [[6r1c]], [[6r1k]], [[6r1w]], [[6r1x]] – MgCRBN 4 + effector<br /> | ||
+ | |||
+ | *'''Ubiquitin protein ligase CHFR''' | ||
+ | |||
+ | **[[2xoc]], [[2xoy]], [[2xoz]] – hUPL C terminal + nucleotide<br /> | ||
+ | **[[2xp0]] – hUPL C terminal <br /> | ||
*'''Ubiquitin protein ligase CHIP''' | *'''Ubiquitin protein ligase CHIP''' | ||
**[[4kbq]] – hUPL TPR domain + Hsc70<br /> | **[[4kbq]] – hUPL TPR domain + Hsc70<br /> | ||
+ | **[[6efk]], [[6nsv]] – hUPL TPR domain + Hsc70 peptide<br /> | ||
*'''Ubiquitin protein ligase CNOT4''' | *'''Ubiquitin protein ligase CNOT4''' | ||
Line 102: | Line 104: | ||
**[[2m6m]] – hUPL RING domain - NMR<br /> | **[[2m6m]] – hUPL RING domain - NMR<br /> | ||
- | *'''Ubiquitin protein ligase | + | *'''Ubiquitin protein ligase DTX''' |
- | **[[3pg6]] – hUPL C terminal <br /> | + | **[[6y5n]] – hUPL 1 RING-DTC domain <br /> |
+ | **[[6y5p]] – hUPL 1 RING-DTC domain + NAD<br /> | ||
+ | **[[3pg6]] – hUPL L3 C terminal <br /> | ||
*'''Ubiquitin protein ligase E3''' | *'''Ubiquitin protein ligase E3''' | ||
Line 169: | Line 173: | ||
**[[6fyh]] – hUPL residues 4255-4374 (mutant) + ubiquitin<br /> | **[[6fyh]] – hUPL residues 4255-4374 (mutant) + ubiquitin<br /> | ||
- | *'''Ubiquitin protein ligase | + | *'''Ubiquitin protein ligase IpaH''' |
- | **[[5b0n]], [[5bot]] – | + | **[[5b0n]], [[5bot]] – SfUPL LRR domain – ''Shigella flexneri'' <br /> |
+ | **[[6lol]] – SfUPL <br /> | ||
*'''Ubiquitin protein ligase ITCHY''' Domains: C2 1-155; WW3 282-320; WW4 324-363; HECT 524-903 | *'''Ubiquitin protein ligase ITCHY''' Domains: C2 1-155; WW3 282-320; WW4 324-363; HECT 524-903 | ||
Line 333: | Line 338: | ||
**[[5hqg]] – hUPL 2 <br /> | **[[5hqg]] – hUPL 2 <br /> | ||
**[[6igq]] – hUPL 2 WD3-repeat domain + Trib peptide <br /> | **[[6igq]] – hUPL 2 WD3-repeat domain + Trib peptide <br /> | ||
- | **[[6cvz]] – hUPL 3 | + | **[[6cvz]] – hUPL 3 WD40-repeat domain <br /> |
+ | |||
+ | *'''Ubiquitin protein ligase RGLG1''' | ||
+ | |||
+ | **[[6k8b]], [[6k8a]], [[6k87]], [[6k88]], [[6k89]] – AtUPL VWA domain <br /> | ||
+ | **[[6k82]], [[6k83]], [[6k85]], [[6k86]] – AtUPL VWA domain (mutant)<br /> | ||
*'''Ubiquitin protein ligase RING2''' | *'''Ubiquitin protein ligase RING2''' | ||
Line 358: | Line 368: | ||
**[[2n9o]] – hUPL 126 N-terminal - NMR<br /> | **[[2n9o]] – hUPL 126 N-terminal - NMR<br /> | ||
**[[3icu]] – hUPL 128 protease-associated domain <br /> | **[[3icu]] – hUPL 128 protease-associated domain <br /> | ||
- | **[[3v3l]] – hUPL 146 | + | **[[6l99]] – hUPL 144A N-terminal - NMR<br /> |
+ | **[[3v3l]] – hUPL 146 zinc finger <br /> | ||
**[[5d0i]] – hUPL 165 residues 255-348 <br /> | **[[5d0i]] – hUPL 165 residues 255-348 <br /> | ||
**[[3l11]], [[4gb0]] – hUPL 168 RING domain <br /> | **[[3l11]], [[4gb0]] – hUPL 168 RING domain <br /> | ||
Line 390: | Line 401: | ||
**[[2rsf]] – mUPL 146 WWE domain + ATP<br /> | **[[2rsf]] – mUPL 146 WWE domain + ATP<br /> | ||
**[[4qpl]] – mUPL 146 RING+WWE domains + E2<br /> | **[[4qpl]] – mUPL 146 RING+WWE domains + E2<br /> | ||
+ | **[[6tax]] – mUPL 213 + ATP - Cryo EM<br /> | ||
+ | **[[6tay]] – mUPL 213 (mutant) + ATP - Cryo EM<br /> | ||
*'''Ubiquitin protein ligase RSP''' | *'''Ubiquitin protein ligase RSP''' | ||
Line 456: | Line 469: | ||
**[[4m3l]] – hUPL 63 coiled-coil domain <br /> | **[[4m3l]] – hUPL 63 coiled-coil domain <br /> | ||
**[[4nqj]] – hUPL 69 coiled-coil domain <br /> | **[[4nqj]] – hUPL 69 coiled-coil domain <br /> | ||
+ | **[[6yxe]] – hUPL 69 RING domain<br /> | ||
**[[3kb5]] – hUPL 72 PRY-SPRY domain <br /> | **[[3kb5]] – hUPL 72 PRY-SPRY domain <br /> | ||
**[[2v0k]] – mUPL 21 PRY-SPRY domain <br /> | **[[2v0k]] – mUPL 21 PRY-SPRY domain <br /> | ||
**[[4b8e]] – mUPL 25 PRY-SPRY domain <br /> | **[[4b8e]] – mUPL 25 PRY-SPRY domain <br /> | ||
+ | **[[6fpt]] – zUPL 71 - zebrafish<br /> | ||
*'''Ubiquitin protein ligase TRIM complexes''' | *'''Ubiquitin protein ligase TRIM complexes''' | ||
Line 469: | Line 484: | ||
**[[3u5n]], [[3u5o]], [[3u5p]], [[5mr8]] – hUPL 33 PHD+Bromo domain + H3-histone peptide <br /> | **[[3u5n]], [[3u5o]], [[3u5p]], [[5mr8]] – hUPL 33 PHD+Bromo domain + H3-histone peptide <br /> | ||
**[[3zo0]] – mUPL 21 PRY-SPRY domain + IG γ-2A<br /> | **[[3zo0]] – mUPL 21 PRY-SPRY domain + IG γ-2A<br /> | ||
+ | **[[6fq3]], [[6fql]] – zUPL 71 + RNA<br /> | ||
*'''Ubiquitin protein ligase UBR''' | *'''Ubiquitin protein ligase UBR''' | ||
Line 496: | Line 512: | ||
**[[4tvr]] – hUPL 2 TUDOR + PHD domains <br /> | **[[4tvr]] – hUPL 2 TUDOR + PHD domains <br /> | ||
**[[2zkg]] – mUPL 1 SRA domain <br /> | **[[2zkg]] – mUPL 1 SRA domain <br /> | ||
+ | **[[6vee]] – mUPL 1 TTD domain - NMR<br /> | ||
+ | **[[6vfo]] – mUPL 1 PHD finger - NMR <br /> | ||
*Ubiquitin protein ligase UHRF complex | *Ubiquitin protein ligase UHRF complex |
Revision as of 10:54, 5 January 2021
3D Structures of ubiquitin protein ligase
Updated on 05-January-2021 - For a general description of the protein see Ubiquitin protein ligase